About Lifecode
Lifecode is a Healthcare company based in Foster City (United States) founded in 2012, and was acquired by MedGenome in February 2016. Molecular tumor profiling panels for solid tumors are developed. Lifecode has raised $20.5 million across 1 funding round from investors including MedGenome, Sequoia Capital and Mayo Clinic Business Accelerator. Lifecode offers products and services including Pan Cancer Somatic Panel. Its focus areas include Life Sciences, Genomics, Applied Genomics and Clinical Genomics. Its legal entity is Lifecode, Inc. Its competitors include GRAIL, Color and Invitae; 3 of its 3 listed competitors have raised funding.
Company details
Lifecode was founded in 2012 in Foster City, United States, as a CLIA-certified laboratory focused on oncology diagnostics. Panels for complete molecular profiling of solid tumors are developed and offered, with the flagship Pan Cancer Somatic Panel analyzing 52 genes linked to metastatic cancers, rare diseases, and clinical trials. The company was acquired by MedGenome in 2016, continuing operations in the biotechnology sector.
- Headquarters Foster City, United States
- Stage Acquired
- SectorsHealthcare
- Website lifecodehealth.com
- Social LinkedIn X
- Acquired by MedGenome (Feb 2016)
- Legal Name Lifecode, Inc.
Products & Services of Lifecode
Lifecode offers a comprehensive portfolio of products and services, including Pan Cancer Somatic Panel.
Assay for profiling tumors using next-generation sequencing data.
Funding Insights of Lifecode
Lifecode has successfully raised a total of $20.5M through 1 strategic funding round. The most recent funding activity was a Series A round of $20.5 million completed in February 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $20.5M
- Total Rounds 1
- Last Round Series A — $20.5M
- First Round $20.5M
(Feb 2015)
- Investors Count 2
All 1 funding rounds of Lifecode with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2015 | $20.5M | Series A | – | Sequoia Capital, Mayo Clinic Business Accelerator | – |
3 investors in total: 3 institutional.
Investors in Lifecode
Lifecode has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include MedGenome, Sequoia Capital and Mayo Clinic Business Accelerator.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Sequoia Capital is engaged in venture capital investments. | 1972 | sequoiacap.com | ||
Healthcare startups are accelerated by Mayo Clinic Business Accelerator. | mcbusaccel.com | Rochester, United States | ||
DNA sequencing, bioinformatics, and multiomics services are provided. | 2013 | medgenome.com | Bengaluru, India |
Investor details for Lifecode
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Lifecode
6 people are tracked at Lifecode (5 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Burt Demill | Chief Commercial Officer | Leadership |
Helen Wang | Founding Member & Head, Curation & Quality | Leadership |
Dietrich Stephan | Founding Member & Scientist in Chief | Leadership |
Chris Rivest | CEO | Leadership |
Timothy Triche | Lab Director | Leadership |
Ahodegnon Salem Bruno | Responsable De La Communauté En Ligne | Team |
Complete people profiles for Lifecode
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Lifecode
3 dated milestones of Lifecode across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Lifecode is founded.
- Funding First funding round of $20.5M.
- Exit Acquired by MedGenome.
Competitors of Lifecode
Lifecode has 3 listed competitors in our database, 3 of them funded. They include GRAIL, Color and Invitae.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| grail.com | 2016 | Menlo Park, United States | $2B | 491 | Circulating tumor DNA is screened for early cancer detection. | |
| color.com | 2013 | Burlingame, United States | $491.44M | 687 | Cancer care is delivered through a virtual clinic by Color. | |
| invitae.com | 2010 | San Francisco, United States | $189.56M | 1,700 | Home-based genetic tests for detecting diseases are provided to individuals. |
Detailed competitors of Lifecode
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Lifecode (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Lifecode
Lifecode was founded in 2012 and raised its 1st funding round 3 years after it was founded.
Lifecode is headquartered in Foster City, United States. It is registered at Foster City, California, United States.
Lifecode is a funded company, having raised a total of $20.5M across 1 funding round to date. The company's 1st funding round was a Series A of $20.5M, raised on Feb 2015.
Lifecode was founded in 2012 in Foster City, United States, as a CLIA-certified laboratory focused on oncology diagnostics. Panels for complete molecular profiling of solid tumors are developed and offered, with the flagship Pan Cancer Somatic Panel analyzing 52 genes linked to metastatic cancers, rare diseases, and clinical trials. The company was acquired by MedGenome in 2016, continuing operations in the biotechnology sector.
Lifecode offers Pan Cancer Somatic Panel.
Lifecode has 3 investors. Key investors include MedGenome, Sequoia Capital, and Mayo Clinic Business Accelerator.
Lifecode operates through Lifecode, Inc..
Yes. Lifecode was acquired by MedGenome in February 2016.